PSMB2
Overview[edit | edit source]
PSMB2 (Proteasome Subunit Beta Type-2) is a protein that in humans is encoded by the PSMB2 gene. It is a component of the 20S core proteasome complex, which is involved in the degradation of ubiquitinated proteins. This process is crucial for maintaining cellular protein homeostasis by removing damaged or misfolded proteins and regulating the concentration of specific proteins to control various cellular processes.
Structure[edit | edit source]
The PSMB2 protein is a part of the beta subunit family of the proteasome complex. The 20S proteasome core is composed of 28 subunits arranged in four stacked rings, forming a barrel-like structure. The two outer rings consist of seven alpha subunits, while the two inner rings consist of seven beta subunits, including PSMB2. The beta subunits are responsible for the proteolytic activity of the proteasome.
Function[edit | edit source]
PSMB2 plays a critical role in the proteolytic function of the proteasome. The proteasome degrades proteins by cleaving peptide bonds in an ATP-dependent manner. This degradation process is essential for various cellular processes, including:
- Cell cycle regulation
- Apoptosis
- DNA repair
- Antigen processing for MHC class I presentation
The activity of the proteasome is tightly regulated, and dysregulation can lead to diseases such as cancer, neurodegenerative disorders, and autoimmune diseases.
Clinical Significance[edit | edit source]
Alterations in the expression or function of PSMB2 have been implicated in several diseases. For example, overexpression of PSMB2 has been observed in certain types of cancer, suggesting a role in tumorigenesis. Additionally, mutations or dysregulation of proteasome components, including PSMB2, can contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Research and Therapeutic Implications[edit | edit source]
The proteasome, including PSMB2, is a target for therapeutic intervention in various diseases. Proteasome inhibitors, such as bortezomib, are used in the treatment of multiple myeloma and certain types of lymphoma. These inhibitors work by blocking the proteolytic activity of the proteasome, leading to the accumulation of proteins that induce apoptosis in cancer cells.
Also see[edit | edit source]
| PSMB2 | |
|---|---|
| Identifiers | |
| Symbol | ? |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
